文献速递胸部肿瘤放疗放疗物理与技术

基于4DCT与CBCT的SBRT中贴壁或膈肌非小细胞肺癌PTV边界研究

4DCT and CBCT based PTV margin in Stereotactic Body Radiotherapy(SBRT) of non-small cell lung tumor adhered to chest wall or diaphragm.
PubMed 文献 · Radiat Oncol · 2016-11-15

本研究纳入20例肿瘤位于下叶且贴附胸壁或膈肌的NSCLC患者,利用4DCT评估分次内肿瘤质心与边界变化,CBCT评估分次间摆位位移,并计算PTV边界。结果显示SI方向质心变化达1.37±0.81 cm,补偿不确定性所需PTV边界在RL、AP、SI方向分别为0.88、0.98、2.68 cm,提示传统SI方向1.0 cm边界不足。

要点

  • SI方向肿瘤质心变化最大,均值1.37±0.81 cm。
  • 补偿不确定性PTV边界SI方向达2.68 cm,为各公式中最大。
  • 传统SI方向1.0 cm边界不足以补偿此类肿瘤几何变化。

核心结论

  • 4DCT与CBCT成像适用于评估分次内肿瘤质心、边界变化及分次间摆位位移。
  • 可据此获得补偿肺癌肿瘤变化不确定性的PTV边界。
  • 对于位于下叶且贴附胸壁和膈肌的肿瘤,传统SI方向1.0 cm边界不足以补偿其几何变化。

研究设计与样本

  • 研究纳入20例接受SBRT的肿瘤位于下叶且贴附胸壁或膈肌的肺癌患者。
  • 模拟定位时采集4DCT评估分次内肿瘤质心与边界变化,每次治疗时采集CBCT评估分次间摆位位移。
  • 采用现有文献发表的多种边界计算公式计算补偿肿瘤变化不确定性的PTV边界。

主要发现

  • 肿瘤质心变化均值(±标准差)在RL、AP、SI方向分别为0.16±0.13 cm、0.22±0.15 cm、1.37±0.81 cm。
  • 肿瘤边界变化均值(±标准差)在RL、AP、SI方向分别为0.21±0.18 cm、0.50±0.23 cm、0.19±0.44 cm。
  • 肿瘤摆位位移均值(±标准差)在RL、AP、SI方向分别为0.03±0.24 cm、0.02±0.26 cm、0.02±0.43 cm。
  • 补偿肿瘤变化不确定性的PTV边界在RL、AP、SI方向分别为0.88、0.98、2.68 cm,为所有边界公式中最大值。

关键数值与推荐

  • PTV边界(补偿肿瘤变化不确定性)在RL方向为0.88 cm。
  • PTV边界(补偿肿瘤变化不确定性)在AP方向为0.98 cm。
  • PTV边界(补偿肿瘤变化不确定性)在SI方向为2.68 cm。

临床怎么用

  • 对下叶贴附胸壁或膈肌的NSCLC行SBRT时,应基于4DCT和CBCT个体化评估肿瘤运动与摆位误差。
  • SI方向不宜沿用传统1.0 cm边界,需按计算结果适当扩大以覆盖几何不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Large tumor motion often leads to larger treatment volumes, especially the lung tumor located in lower lobe and adhered to chest wall or diaphragm. The purpose of this work is to investigate the impacts of planning target volume (PTV) margin on Stereotactic Body Radiotherapy (SBRT) in non-small cell lung cancer (NSCLC). METHODS: Subjects include 20 patients with the lung tumor located in lower lobe and adhered to chest wall or diaphragm who underwent SBRT. Four-dimensional computed tomography (4DCT) were acquired at simulation to evaluate the tumor intra-fractional centroid and boundary changes, and Cone-beam Computer Tomography (CBCT) were acquired during each treatment to evaluate the tumor inter-fractional set-up displacement. The margin to compensate for tumor variations uncertainties was calculated with various margin calculated recipes published in the exiting literatures. RESULTS: The means (±standard deviation) of tumor centroid changes were 0.16 (±0.13) cm, 0.22 (±0.15) cm, and 1.37 (±0.81) cm in RL, AP, and SI directions, respectively. The means (±standard deviation) of tumor edge changes were 0.21 (±0.18) cm, 0.50 (±0.23) cm, and 0.19 (±0.44) cm in RL, AP, and SI directions, respectively. The means (±standard deviation) of tumor set-up displacement were 0.03 (±0.24) cm, 0.02 (±0.26) cm, and 0.02 (±0.43) cm in RL, AP, and SI directions, respectively. The PTV margin to compensate for lung cancer tumor variations uncertainties were 0.88, 0.98 and 2.68 cm in RL, AP and SI directions, which were maximal among all margin recipes. CONCLUSIONS: 4DCT and CBCT imaging are appropriate to account for the tumor intra-fractional centroid, boundary variations and inter-fractional set-up displacement. The PTV margin to compensate for lung cancer tumor variations uncertainties can be obtained. Our results show that a conventional 1.0 cm margin in the SI plane dose not suffice to compensate the geometrical variety of the tumor located in lower lobe and adhered to chest wall and diaphragm.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Li Y, Ma JL, Chen X, et al. 4DCT and CBCT based PTV margin in Stereotactic Body Radiotherapy(SBRT) of non-small cell lung tumor adhered to chest wall or diaphragm. Radiat Oncol. 2016. PMID: 27846900

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。